National Cancer Centre Singapore will NEVER ask you to transfer money over a call. If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg.

Dr Bok Ke Xin

BSc. (Pharmacy)(Hons), MD, MRCP(UK), MMed (Int. Med)

Associate Consultant

National Cancer Centre Singapore National Cancer Centre Singapore

Conditions Treated By This Doctor

Clinical Interests

Breast, Gynae-Oncology

Clinical Appointments

About Doctor

Dr Bok Ke Xin is an Associate Consultant Medical Oncologist at NCCS, subspecialising in breast and gynaecological cancers. She graduated from Duke-NUS Medical School in 2018 with multiple academic awards and completed her postgraduate qualifications in internal medicine; earning her MRCP(UK) and MMed (Internal Medicine) in 2022 and specialist accreditation in medical oncology in 2026. She has a keen interest in translational and clinical research in breast and gynecological oncology, particularly in clinical trials and biomarker-driven therapeutics.

Languages Spoken

  • English
  • Chinese

Education and Training

  • MMed (Internal Medicine), National University of Singapore, 2023 
  • MRCP (UK), Royal College of Physicians, 2022 
  • MD, Duke-NUS Medical School, 2018 
  • BSc (Pharmacy), First Class Honours, National University of Singapore, 2014

Professional Appointments and Committee Memberships

  • Singapore Society of Oncology, Member 
  • American Society of Clinical Oncology, Member 
  • European Society of Medical Oncology, Member

Awards

  • 2026 SingHealth RiSE Outstanding Resident Award 
  • 2022 SingHealth Best Medical Officer Award 
  • 2018 Singapore Medical Association-Lee Foundation Achievement Prize 
  • 2018 Duke-NUS Achievement Prize 
  • 2017 AM-ETHOS Medical Student Research Fellowship Award 
  • 2014 Dean’s List Award

Publications

  • Blood memory CD8 T cell phenotypes in lung cancer patients predict immune checkpoint treatment responses. F Schmidt, KX Wu, YI Purwanti, NYZ Tan, D Carbajo, KX Bok, A Wilm et al. Frontiers in Oncology. Sep 2025; 15, 1629802 
  • Second-line antibody-drug conjugates for the treatment of metastatic human papillomavirus-independent gastric-type adenocarcinoma of cervix: The Singapore experience. DJM Ang, KX Bok, SL Wong, Y Li, A Wong, YC Yeo, J Wang, IM Aggarwal, JJ Chan. Gynecologic Oncology Reports. Apr 2025; Gynecologic Oncology Reports 58, 101709 
  • High durability and low toxicity antimicrobial coatings fabricated by quaternary ammonium silane co-polymers. H Li, H Bao, KX Bok, CY Lee, B Li, MT Zin, L Kang. Biomaterials science. Jan 2016; 4(2): 299-309.